Quarterly report pursuant to Section 13 or 15(d)

INTERIM STATEMENTS OF OPERATIONS

v3.21.2
INTERIM STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
OPERATING EXPENSES        
Research and Development $ 1,126,972 $ 659,977 $ 1,313,954 $ 1,745,446
General and Administrative 3,515,250 654,569 8,873,160 1,761,561
TOTAL OPERATING EXPENSES 4,642,222 1,314,546 10,187,114 3,507,007
Gain on forgiveness of Paycheck Protection Program Loan     66,503  
NET LOSS $ (4,642,222) $ (1,314,546) $ (10,120,611) $ (3,507,007)
LOSS PER SHARE        
Basic net loss per common share/units $ (0.46) $ (0.21) $ (1.27) $ (0.58)
Diluted net loss per common share/units $ (0.46) $ (0.21) $ (1.27) $ (0.58)
Weighted average pro forma shares outstanding basic 10,116,403 6,266,584 7,988,563 6,037,254
Weighted average pro forma shares outstanding diluted 10,116,403 6,266,584 7,988,563 6,037,254